145 related articles for article (PubMed ID: 21542526)
1. Body mass index of patients with endometrial hyperplasia: comparison to patients with proliferative endometrium and abnormal bleeding.
Heller DS; Mosquera C; Goldsmith LT; Cracchiolo B
J Reprod Med; 2011; 56(3-4):110-2. PubMed ID: 21542526
[TBL] [Abstract][Full Text] [Related]
2. Effects of aromatase inhibitor on menopausal hyperplasia in a case of obesity.
Koloszar S; Pal Z; Kereszturi A; Vajda G; Pal A; Daru J
Climacteric; 2012 Feb; 15(1):93-4. PubMed ID: 22132829
[TBL] [Abstract][Full Text] [Related]
3. Adipose tissue distribution in postmenopausal women with adenomatous hyperplasia of the endometrium.
Gredmark T; Kvint S; Havel G; Mattsson LA
Gynecol Oncol; 1999 Feb; 72(2):138-42. PubMed ID: 10021291
[TBL] [Abstract][Full Text] [Related]
4. Leptin levels in serum depending on Body Mass Index in patients with endometrial hyperplasia and cancer.
Cymbaluk A; Chudecka-Głaz A; Rzepka-Górska I
Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):74-7. PubMed ID: 17007993
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of endometrial hyperplasia in women with abnormal uterine bleeding.
Loverro G; Bettocchi S; Vicino M; Selvaggi L
Acta Eur Fertil; 1994; 25(1):23-5. PubMed ID: 7887077
[TBL] [Abstract][Full Text] [Related]
6. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.
Wise MR; Gill P; Lensen S; Thompson JM; Farquhar CM
Am J Obstet Gynecol; 2016 Nov; 215(5):598.e1-598.e8. PubMed ID: 27287687
[TBL] [Abstract][Full Text] [Related]
7. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
Ozalp S; Kabukcuoglu S; Tanir HM
Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
Ivanov S
Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
[TBL] [Abstract][Full Text] [Related]
9. Possible impact of immunosuppressive therapy regimens on histopathologic outcomes of abnormal uterine bleeding in solid-organ transplant recipients.
Tohma YA; Akilli H; Kirnap M; Haberal AN; Akyel D; Zengin HY; Zeyneloglu HB; Kuscu E; Ayhan A; Haberal M
Clin Transplant; 2018 Aug; 32(8):e13305. PubMed ID: 29851156
[TBL] [Abstract][Full Text] [Related]
10. Persistence of endometrial activity after radiation therapy for cervical carcinoma.
Barnhill D; Heller P; Dames J; Hoskins W; Gallup D; Park R
Obstet Gynecol; 1985 Dec; 66(6):805-8. PubMed ID: 2999661
[TBL] [Abstract][Full Text] [Related]
11. Endometrial thickness predicts endometrial hyperplasia in patients with polycystic ovary syndrome.
McCormick BA; Wilburn RD; Thomas MA; Williams DB; Maxwell R; Aubuchon M
Fertil Steril; 2011 Jun; 95(8):2625-7. PubMed ID: 21550041
[TBL] [Abstract][Full Text] [Related]
12. [Difficulties and mistakes in the diagnosis of atypical endometrial hyperplasia].
Kxmel'nitskaia NM; Neĭshtadt EL; Khalimdzhanov ZK
Arkh Patol; 2006; 68(6):39-42. PubMed ID: 17290894
[TBL] [Abstract][Full Text] [Related]
13. High rate of endometrial hyperplasia in renal transplanted women.
Bobrowska K; Kamiński P; Cyganek A; Pietrzak B; Jabiry-Zieniewicz Z; Durlik M; Paczek L
Transplant Proc; 2006; 38(1):177-9. PubMed ID: 16504696
[TBL] [Abstract][Full Text] [Related]
14. Dysmenorrhea and dysfunctional uterine bleeding.
Apgar BS
Prim Care; 1997 Mar; 24(1):161-78. PubMed ID: 9016734
[TBL] [Abstract][Full Text] [Related]
15. Two-year follow-up of 263 patients with post/perimenopausal vaginal bleeding and negative initial biopsy.
Feldman S; Shapter A; Welch WR; Berkowitz RS
Gynecol Oncol; 1994 Oct; 55(1):56-9. PubMed ID: 7959267
[TBL] [Abstract][Full Text] [Related]
16. Digital morphometry of cytologic aspirate endometrial samples.
Mahovlić V; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Rajhvajn S; Juric D; Projić IS; Ilić-Forko J; Babić D; Skrablin-Kucić S; Bozikov J
Coll Antropol; 2010 Mar; 34(1):45-51. PubMed ID: 20437635
[TBL] [Abstract][Full Text] [Related]
17. Endometrial hyperplasia involving endometrial polyps: report of a series and discussion of the significance in an endometrial biopsy specimen.
Kelly P; Dobbs SP; McCluggage WG
BJOG; 2007 Aug; 114(8):944-50. PubMed ID: 17565613
[TBL] [Abstract][Full Text] [Related]
18. The ability of endometrial biopsies with atypical complex hyperplasia to guide surgical management.
Miller C; Bidus MA; Pulcini JP; Maxwell GL; Cosin JA; Rose GS
Am J Obstet Gynecol; 2008 Jul; 199(1):69.e1-4. PubMed ID: 18241812
[TBL] [Abstract][Full Text] [Related]
19. Clinical pathway for evaluating women with abnormal uterine bleeding.
Dunn TS; Stamm CA; Delorit M; Goldberg G
J Reprod Med; 2001 Sep; 46(9):831-4. PubMed ID: 11584486
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of postmenopausal women with proliferative endometrium on endometrial sampling.
Rotenberg O; Doulaveris G; Fridman D; Renz M; Kaplan J; Xie X; Goldberg GL; Dar P
Am J Obstet Gynecol; 2020 Dec; 223(6):896.e1-896.e7. PubMed ID: 32640199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
